Total planned funding: $326,793,970
Allocations
Countries/Regions
Eswatini | $326,793,970 |
Organizational Types
Private Contractor | $97,958,340 |
University | $61,492,516 |
NGO | $54,497,545 |
Own Agency | $39,638,684 |
Unknown | $38,860,472 |
Multi-lateral Agency | $14,782,982 |
FBO | $9,407,717 |
Host Country Government Agency | $8,548,594 |
Other USG Agency | $1,580,289 |
Implementing Agency | $26,831 |
Program Areas
Care | $105,059,489 |
Treatment | $92,271,728 |
Prevention | $53,812,165 |
Governance and Systems | $29,089,223 |
Testing | $25,932,500 |
Management and Operations | $20,628,865 |
Budget Codes
HTXS: Treatment: Adult Treatment | $64,675,797 |
HBHC: Care: Adult Care and Support | $47,963,591 |
HKID: Care: Orphans and Vulnerable Children | $33,399,960 |
HVCT: Testing: HIV Testing and Counseling | $25,932,500 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,312,876 |
HTXD: Treatment: ARV Drugs | $21,895,009 |
HVMS: Management and Operations | $20,628,865 |
HVOP: Sexual Prevention: Other Sexual Prevention | $17,544,972 |
HVTB: Care: TB/HIV | $15,443,871 |
OHSS: Health Systems Strengthening | $13,364,733 |
HVSI: Strategic Information | $11,524,651 |
PDCS: Care: Pediatric Care and Support | $8,252,067 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,451,056 |
PDTX: Treatment: Pediatric Treatment | $5,700,922 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,589,504 |
HLAB: Laboratory Infrastructure | $4,199,839 |
HMBL: Biomedical Prevention: Blood Safety | $913,757 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$51,442,780
Countries/Regions
Pact, Inc.:
$34,807,903
Countries/Regions
Not Available:
$34,461,486
Countries/Regions
USG Aggregated Agencies:
$26,427,932
Countries/Regions